Long-term benefit of SABR for operable early-stage NSCLC shown in new study
A new study showed that stereotactic ablative radiotherapy (SABR) was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer (NSCLC…
